Azithromycin for Injection Blend from China
Lyophilized bulk blend of azithromycin with lyoprotectants for reconstitution into anti-infective IV solutions treating pneumonia. Classified in 3003.90.01.80 for its mixed constituents, therapeutic anti-infective intent, and lack of retail/measured dosing. Used in large-scale hospital supply chains.
Duty Rate — China → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Submit DMF and validation data for lyophilization process compliance
• Ensure packaging prevents interpretation as 'put up for retail sale'
• Declare as 'other' anti-infectives only if not matching specific subheadings